• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种替代的紫杉醇自乳化微乳制剂:制备、药代动力学特征及超敏反应评估。

An alternative paclitaxel self-emulsifying microemulsion formulation: preparation, pharmacokinetic profile, and hypersensitivity evaluation.

作者信息

Zhang Xue-Nong, Tang Li-Hua, Gong Jin-Hong, Yan Xue-Ying, Zhang Qiang

机构信息

College of Pharmacy, Soochow University, Suzhou 215123, People's Republic of China.

出版信息

PDA J Pharm Sci Technol. 2006 Mar-Apr;60(2):89-94.

PMID:16696191
Abstract

Based on the clinical fact that paclitaxel injection (Taxol) frequently causes hypersensitivity reactions, an alternative paclitaxel self-emulsifying microemulsion was studied with phase diagrams, and the prescription of microemulsion formulation was optimized. Regarding Taxol, the pharmacokinetic parameters of microemulsion and hypersensitivity were investigated in rats and guinea pigs, respectively. The results showed that the self-emulsifying microemulsion was made up of tricaproin:tributyrin 1:1 as the oil phase, ethanol as assist, pluronic F68 and lecithin as emulsifier, and formed a mean diameter of 16 +/- 3 nm when diluted with saline. In the pharmacokinetic study, rats were administrated Taxol or paclitaxel microemulsion. Blood samples were collected at definite time intervals, and plasma concentrations of paclitaxel were determined by high-performance liquid chromatography. The area under the curve was significantly higher in the microemulsion group (33 mg.ml(-1).h) than that in the Taxol group (25 mg.ml(-1).h) (P < 0.01). The constant of transport rate of speed, K10 (0.55 h(-1)), was much smaller in the microemulsion group compared with the Taxol group (1.55 h(-l)). The mean retention time was 3.89 h in microemulsion group and 2.52 h in the Taxol group, showing the elimination rate was much slower in the former than in the latter. Compared with Taxol, the paclitaxel microemulsion caused less toxicity and had a longer circulation time in rats.

摘要

基于紫杉醇注射液(泰素)频繁引起过敏反应这一临床事实,利用相图研究了一种替代的紫杉醇自乳化微乳,并优化了微乳制剂的处方。对于泰素,分别在大鼠和豚鼠中研究了微乳的药代动力学参数及过敏反应。结果表明,该自乳化微乳由辛酸甘油酯:丁酸甘油酯1:1作为油相、乙醇作为助乳化剂、泊洛沙姆F68和卵磷脂作为乳化剂组成,用生理盐水稀释后平均粒径为16±3nm。在药代动力学研究中,给大鼠分别注射泰素或紫杉醇微乳。在确定的时间间隔采集血样,用高效液相色谱法测定血浆中紫杉醇的浓度。微乳组的曲线下面积(33mg·ml⁻¹·h)显著高于泰素组(25mg·ml⁻¹·h)(P<0.01)。微乳组的转运速率常数K10(0.55h⁻¹)远小于泰素组(1.55h⁻¹)。微乳组的平均滞留时间为3.89h,泰素组为2.52h,表明前者的消除速率比后者慢得多。与泰素相比,紫杉醇微乳在大鼠中引起的毒性较小且循环时间更长。

相似文献

1
An alternative paclitaxel self-emulsifying microemulsion formulation: preparation, pharmacokinetic profile, and hypersensitivity evaluation.一种替代的紫杉醇自乳化微乳制剂:制备、药代动力学特征及超敏反应评估。
PDA J Pharm Sci Technol. 2006 Mar-Apr;60(2):89-94.
2
An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile.一种替代的紫杉醇微乳制剂:超敏反应评估及药代动力学特征
Int J Pharm. 2003 Jan 2;250(1):45-50. doi: 10.1016/s0378-5173(02)00478-7.
3
[Studies on hypersensitivity and pharmacokinetics of paclitaxel microemulsion].[紫杉醇微乳剂的过敏反应及药代动力学研究]
Yao Xue Xue Bao. 2003 Mar;38(3):227-30.
4
Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.水飞蓟素及其制剂对紫杉醇在大鼠体内口服生物利用度的影响。
Eur J Pharm Sci. 2012 Feb 14;45(3):296-301. doi: 10.1016/j.ejps.2011.11.021. Epub 2011 Dec 8.
5
Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.紫杉醇无聚氧乙烯蓖麻油静脉注射微乳剂 I:制剂、细胞毒性和溶血作用
Int J Pharm. 2008 Feb 12;349(1-2):108-16. doi: 10.1016/j.ijpharm.2007.07.042. Epub 2007 Aug 7.
6
Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics.紫杉醇的无聚氧乙烯蓖麻油静脉微乳剂II.稳定性、体外释放及药代动力学
Int J Pharm. 2008 Feb 12;349(1-2):117-23. doi: 10.1016/j.ijpharm.2007.07.043. Epub 2007 Aug 7.
7
Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.紫杉醇口服微乳剂:原位及药代动力学研究
Eur J Pharm Biopharm. 2009 Feb;71(2):310-7. doi: 10.1016/j.ejpb.2008.08.015. Epub 2008 Aug 29.
8
Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel.紫杉醇过滤除菌乳剂的处方开发及抗肿瘤活性
Pharm Res. 2000 Feb;17(2):175-82. doi: 10.1023/a:1007565230130.
9
Preparation and characterization of paclitaxel nanosuspension using novel emulsification method by combining high speed homogenizer and high pressure homogenization.采用高速匀浆机联合高压匀浆新乳化法制备紫杉醇纳米混悬剂及制剂学性质考察。
Int J Pharm. 2015 Jul 25;490(1-2):324-33. doi: 10.1016/j.ijpharm.2015.05.070. Epub 2015 May 28.
10
Intravenous administration of paclitaxel in Sprague-Dawley rats: what is a safe dose?
Biopharm Drug Dispos. 2006 May;27(4):191-6. doi: 10.1002/bdd.503.